Quest Diagnostics Acquires MedXM

We represented Quest Diagnostics (NYSE: DGX) in its acquisition of Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. The acquisition will expand Quest’s scale and reach in the mobile/home segment and bolster its overall capabilities in extended care. Terms of the transaction were not publicly disclosed.

Quest Diagnostics is the world’s leading provider of diagnostic information services that patients and doctors need to make better healthcare decisions.

You Also May Be Interested In:

  • Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019.  Serco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.

    We represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation's Naval Systems Business...
    Client Type: Private Company
  • Represented C-III Capital Partners in its sale of California-based tech company Real Capital Markets (RCM) to LightBox

    We represented C-III Capital Partners, a fully-diversified asset management and commercial real estate services company, in its sale of California-based...
    Client Type: Private Company
  • We represented SERVPRO in its recapitalization transaction, in partnership with Blackstone, one of the world’s leading investment firms. Blackstone is...
    Client Type: Private Company